These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16952906

  • 1. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J, Kuca K, Cabal J, Paar M.
    J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K.
    Toxicology; 2008 Jan 20; 243(3):311-6. PubMed ID: 18054821
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M, Vrdoljak AL, Radić B, Jelić D, Jun D, Kuca K, Kovarik Z.
    Toxicology; 2006 Feb 15; 219(1-3):85-96. PubMed ID: 16332406
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K, Kopelikova I.
    J Enzyme Inhib Med Chem; 2009 Aug 15; 24(4):1040-4. PubMed ID: 19552519
    [Abstract] [Full Text] [Related]

  • 5. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J, Jun D, Karasova J, Bajgar J, Kuca K.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):425-7. PubMed ID: 18547554
    [Abstract] [Full Text] [Related]

  • 6. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.
    Toxicol Mech Methods; 2011 Mar 25; 21(3):241-5. PubMed ID: 21142778
    [Abstract] [Full Text] [Related]

  • 7. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
    Berend S, Vrdoljak AL, Radić B, Kuca K.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):413-6. PubMed ID: 18547553
    [Abstract] [Full Text] [Related]

  • 8. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J, Karasova JZ, Caisberger F, Musilek K, Kuca K, Jung YS.
    J Enzyme Inhib Med Chem; 2010 Aug 25; 25(4):480-4. PubMed ID: 20233085
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice.
    Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K.
    J Enzyme Inhib Med Chem; 2008 Dec 25; 23(6):776-80. PubMed ID: 18608751
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J, Sepsova V, Musilek K, Horova A.
    Toxicol Mech Methods; 2013 Feb 25; 23(2):94-8. PubMed ID: 22901042
    [Abstract] [Full Text] [Related]

  • 11. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Misik J, Caisberger F, Bajgar J.
    J Appl Toxicol; 2010 Mar 25; 30(2):120-4. PubMed ID: 19746406
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Jung YS.
    Drug Chem Toxicol; 2008 Mar 25; 31(3):371-81. PubMed ID: 18622871
    [Abstract] [Full Text] [Related]

  • 13. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J.
    Clin Toxicol (Phila); 2009 Jan 25; 47(1):72-6. PubMed ID: 18686075
    [Abstract] [Full Text] [Related]

  • 14. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J, Hajek P, Zdarova JK, Kassa J, Paseka A, Slizova D, Krs O, Kuca K, Jun D, Fusek J, Capek L.
    J Enzyme Inhib Med Chem; 2010 Dec 25; 25(6):790-7. PubMed ID: 21054236
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J, Kunesova G.
    J Appl Toxicol; 2006 Dec 25; 26(4):309-16. PubMed ID: 16552727
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A, Calić M, Radić B, Berend S, Jun D, Kuca K, Kovarik Z.
    Toxicology; 2006 Nov 10; 228(1):41-50. PubMed ID: 16982122
    [Abstract] [Full Text] [Related]

  • 17. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K, Cabal J.
    Cent Eur J Public Health; 2004 Mar 10; 12 Suppl():S59-61. PubMed ID: 15141981
    [Abstract] [Full Text] [Related]

  • 18. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
    Kovarik Z, Calić M, Sinko G, Bosak A, Berend S, Vrdoljak AL, Radić B.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):173-9. PubMed ID: 18501341
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K, Cabal J, Kassa J.
    Pharmazie; 2004 Oct 25; 59(10):795-8. PubMed ID: 15544060
    [Abstract] [Full Text] [Related]

  • 20. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
    Kassa J, Karasova JZ, Sepsova V, Caisberger F.
    Basic Clin Pharmacol Toxicol; 2011 Jul 25; 109(1):30-4. PubMed ID: 21235715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.